AzTrials
AzTrials

Osteoarthritis (Knee)RoboTKANCT07914036

Patient Satisfaction After Robotic-Assisted Versus Conventional Total Knee Arthroplasty

A study testing Mako4 Robotic Arm Assisted Total Knee Arthroplasty and conventional total knee arthroplasty using Triathlon Total Knee System in people with Osteoarthritis (Knee) and Robotic Assisted Arthroplasty, run by Ain Shams University at 1 site in Egypt.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Total knee arthroplasty (TKA) remains the definitive treatment for advanced knee osteoarthritis and continues to be performed with increasing frequency worldwide. However, patient dissatisfaction remains reported in up to one-fifth of cases, despite technically successful procedures and acceptable radiographic… Read more about this study

Who is it for?
Ages 50 years and older
What is being tested?
Mako4 Robotic Arm Assisted Total Knee Arthroplasty and conventional total knee arthroplasty using Triathlon Total Knee System
Could I receive a placebo?
No, everyone receives an active treatment
How many people
70 participants
Where
1 siteEgypt
Study dates
30 Oct 2026to 30 Apr 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients with symptomatic end-stage primary knee osteoarthritis.

Who cannot join

  • Body mass index (BMI) (> 40 kg/m²)
  • Significant coronal deformity (>20° varus deformity and >15° valgus deformity)
  • Significant flexion deformity (>15° flexion deformity)
  • Previous major knee surgery (high tibial osteotomies (HTO) , osteosynthesis) excluding surgeries not affecting joint line e.g.: knee arthroscopies (meniscal repair)
  • Secondary OA (post traumatic or post infectious)
  • Significant osteoporosis or bone loss ▪ Musculoskeletal disease impairing gait/function e.g., spine or hip disabling disorders
Show all 9Show fewer
  • Extra-articular lower limb deformities necessitating additional surgical intervention
  • American Society of Anesthesiologists (ASA) score more than stage 3
  • Poorly controlled Diabetic and hypertensive patients. ▪ Septic focus necessitating eradication e.g., dental caries, chest infection, diabetic foot.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Abdelrahman Amir AbouElEla, Msc contact

1099353380 ext. +20

abdelrahman.amir.medorth@gmail.com

Egypt1 site
  • Ainshams university

    Cairo, 1181

    Abdelrahman Amir AbouElEla, Msc, 01099353380 ext. +20, abdelrahman.amir.medorth@gmail.com

Other trials in Egypt

About this study

Official title: Patient Satisfaction After Robotic-Assisted Versus Conventional Total Knee Arthroplasty: A Randomized Controlled Trial

Total knee arthroplasty (TKA) remains the definitive treatment for advanced knee osteoarthritis and continues to be performed with increasing frequency worldwide. However, patient dissatisfaction remains reported in up to one-fifth of cases, despite technically successful procedures and acceptable radiographic results. This discrepancy has shifted attention toward early functional recovery and patient-reported outcomes as more meaningful indicators of success. In response, technological innovations such as robotic-assisted total knee arthroplasty have been introduced to enhance surgical precision and reduce alignment outliers. This study aims to determine whether these technical advantages translate into improved early clinical outcomes by comparing patient satisfaction, functional results, radiological accuracy, and perioperative parameters between robotic-assisted and conventional total knee arthroplasty over one year.

Read the detailed description
  • Type of Study: Randomized controlled trial.
  • Study Setting: Ain Shams University hospitals
  • Sampling Method: Consecutive sampling.
  • Sample Size: A minimum of 70 patients with symptomatic end-stage primary knee osteoarthritis who meet the inclusion and exclusion criteria will be enrolled and randomly allocated into two groups, with 35 patients in each group.
  • Study procedures:

Two-arm, parallel-group, randomized controlled trial comparing Mako4 robotic-arm assisted total knee arthroplasty with conventional total knee arthroplasty. Participants will be allocated in a 1:1 ratio using simple computer-generated randomization. Allocation will be concealed by an off-site holder of the randomization sequence who is independent of participant enrollment and outcome assessment. Outcome assessors will be blinded to treatment allocation, while participants and the operating surgical team will not be blinded because of the nature of the interventions.

Group A: Conventional Total Knee Arthroplasty (C-TKA). Group B: Robotic-Assisted Total Knee Arthroplasty (RA-TKA).

  1. Primary (Preoperative) Diagnosis and Evaluation:
  2. Clinical Evaluation
  3. history
  • Age, sex, occupation, level of activity, comorbidities, medical and surgical history
  • To assess (BMI), The American Society of Anesthesiologists (ASA) score
  1. General examination:
  • Vital data (Heart Rate, Respiratory Rate, Blood Pressure, and peripheral pulsations)
  • The Charnley Functional Classification based on patients' overall physical condition and comorbidities
  • ligamentous laxity
  • Spine, hip, foot and ankle examination
  • Signs of inflammatory arthropathies (RA or SPA)
  1. local examination
  • Inspection, palpation, range of motion and special tests for ligaments integrity
  • Preoperative scores: Oxford Knee Score (OKS), and 2011 Knee Society Score (KSS) objective knee indicators, Symptoms, Functional Activities, and Expectations Domains.
  1. Radiological Evaluation:

PLAIN FILMS

  • Weight bearing Anteroposterior (AP) knee Xrays
  • Lateral knee Xrays (with knees in 30 ° flexion) to assess patellar height and component position
  • Merchant view to assess the patella and the patellofemoral joint.
  • Standing long-leg radiographs, obtained with the patellae facing forward and the feet flat on the ground
  1. Overall, Limb Alignment
  • Hip-Knee-Ankle angle (HKA)
  • Mechanical axis deviation (MAD)
  1. Femoral and tibial Parameters
  • Mechanical Lateral Distal Femoral Angle (mLDFA)
  • Mechanical Medial Proximal Tibial Angle (mMPTA)
  1. Joint-Related Angles
  • Joint Line Convergence Angle (JLCA)
  1. Deformity Analysis
  • Site (femoral vs tibial) and magnitude of deformity
  1. preoperative patient preparation:
  • All patients will undergo preoperative laboratory investigations (CBC with differentials, HBA1C, Bun, creatinine, Na, K, ALT, AST, PT, PTT, INR and Virology (HIV, HCV, HBV)
  • ECG and echocardiogram to assess cardiac function
  • Corresponding medical consultation according to their comorbidities II. intraoperative management: All patients will be managed by the same surgical team following a standardized perioperative protocol. Surgery will be performed with the patient in the supine position. Prophylactic intravenous antibiotics will be administered 30 minutes prior to skin incision in accordance with hospital policy, using weight-adjusted dosing. Above-knee pneumatic tourniquet will be applied in all cases. A standard medial parapatellar approach will be utilized. Total knee arthroplasty will be performed either using a conventional manual jig-based technique (C-TKA) (Group A) with a Fixed-bearing Posterior- Stabilized (PS) implants or robotic-assisted total knee arthroplasty (RA-TKA) (Group B), according to patient allocation. All implants and instrumentation will be provided by the same company (STRYKER). Regardless of surgical technique, all TKAs will be performed using cemented fixation. Stem extensions will be selectively used on a case-by-case basis in the presence of obesity, osteoporosis, or significant bone defects. The patella will be managed with conventional patelloplasty in all patients. Closed-suction drains will be used routinely. III. Postoperative management and follow up:
  1. Rehab and medications: All patients will receive the same
  • TKA education.
  • Postoperative antibiotic and analgesia regimens (including Patient controlled Analgesia (PCA)).
  • Venous thromboembolism prophylaxis protocol.
  • Postoperative isometric quadriceps exercises, ankle pumps and straight leg raises
  • Encouragement of immediate postoperative weight-bearing as tolerated on the day of surgery using a walker, along with initiation of early knee range-of-motion exercises.
  • Postoperative CBC, wound and drain follow up
  1. Radiological study:
  • Immediate postoperative Xray knees Ap, lateral and if applicable; merchant view To check for implant position, retained cement and periprosthetic fractures.

With follow up at 6 weeks, 3months , 6 months and 1 year.

  • Radiological outcomes will be assessed using the (KSRES) in the immediate postoperative period and at 6 months and 1 year postoperatively. The KSRES will be utilized to evaluate component alignment and positioning, radiolucent lines, osteolysis, component migration, and signs of aseptic loosening or implant failure,
  • Standing long-leg radiographs, obtained with the patella facing forward and the feet flat on the ground, will be used to assess mechanical axis deviation and identify alignment outliers, defined as any postoperative alignment measurement deviating by more than 3° from the planned target alignment.
  1. Computed tomography (CT) of the operated knee will be performed in the immediate postoperative period to assess femoral and tibial component rotational alignment and overall implant rotational profile.
  2. Functional score At follow-up visits, the FJS-12, OKS, and ((2011 KSS) objective knee parameters, Symptoms, Functional Activities, fulfilled Expectations, and Satisfaction domains) will be recorded at 6 weeks, 3 months, 6 months, and 1 year and compared between both groups throughout follow-up.
  3. Complications will be monitored and managed accordingly, e.g.: DVT, infection, periprosthetic fracture, implant loosening or failure .

Statistical Analysis:

By using Power Analysis and Sample Size Software (PASS 15) (Version 15.0.10) for sample size calculation, with a power of 80% and a significance level of 0.05, based on previous study results (Bollars et al., 2025), which reported that among patients undergoing total knee arthroplasty (TKA), patient satisfaction measured by FJS-12 was higher in those who underwent robotic-assisted TKA (mean 73.2 ± 23.3) compared to conventional instrumented TKA (mean 53.6 ± 29.0), and accounting for a 10% dropout rate; a sample size of at least 70 patients presenting with symptomatic end-stage primary knee osteoarthritis divided randomly into 2 groups (35 patients in each group) will be needed.

Being tested
Mako4 Robotic Arm Assisted Total Knee Arthroplasty, conventional total knee arthroplasty using Triathlon Total Knee System
Keywords
Total knee arthroplasty, Robotic assisted arthroplasty, Jig-based arthroplasty, Conventional knee arthroplasty, osteoarthritis
Medical subject headings
Osteoarthritis, Knee, Osteoarthritis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Mako4 Robotic Arm Assisted Total Knee ArthroplastyDevice

    Also called Mako 4 SmartRobotics™, Mako 4.0, Stryker Mako 4, Mako Fourth Generation System

    All patients will be managed by the same surgical team , performed with the patient in supine position. Prophylactic intravenous antibiotics will be administered 30 minutes before skin incision , using weight-adjusted dosing. An above-knee pneumatic tourniquet will be applied in all cases, and a standard medial parapatellar approach will be used.

    Patients allocated to the robotic-assisted group will undergo total knee arthroplasty using the Mako Robotic-Arm Assisted System (Stryker, Kalamazoo, Michigan, USA) with the Triathlon Total Knee System. Robotic assistance will be used for preoperative/intraoperative surgical planning, bone preparation, component positioning, and intraoperative assessment of soft-tissue balance. In both groups, all components will be implanted using cemented fixation. Stem extensions may be used selectively on a case-by-case basis.The patella will be managed with conventional patelloplasty in all patients. Closed-suction drains will be used routinely.

  • conventional total knee arthroplasty using Triathlon Total Knee SystemProcedure or surgery

    Also called Manual Triathlon TKA:, Conventional Total Knee Arthroplasty (TKA), Triathlon Primary Total Knee System, Jig-based Total Knee Arthroplasty (TKA)

    All patients will be managed by the same surgical team , performed with the patient in supine position. Prophylactic intravenous antibiotics will be administered 30 minutes before skin incision , using weight-adjusted dosing. An above-knee pneumatic tourniquet will be applied in all cases, and a standard medial parapatellar approach will be used.

    Patients allocated to the conventional (control) group will undergo total knee arthroplasty using the Triathlon Total Knee System (Stryker, Kalamazoo, Michigan, USA) with standard manual instrumentation and conventional cutting jigs, without robotic assistance. Component sizing, bone preparation, positioning, and soft-tissue balancing will be performed using standard conventional techniques. All components will be implanted using cemented fixation. Stem extensions may be used selectively on a case-by-case basis. The patella will be managed with conventional patelloplasty in all patients. Closed-suction drains will be used routinely.

Study groups in NCT07914036
Study groupRoleWhat they receive
Mako4 Robotic Arm Assisted Total Knee ArthroplastyExperimentalAll patients will be managed by the same surgical team , performed with the patient in supine position. Prophylactic intravenous antibiotics will be administered 30 minutes before skin incision , using weight-adjusted dosing. An above-knee pneumatic tourniquet will be applied in all cases, and a standard medial parapatellar approach will be used. Patients allocated to the robotic-assisted group will undergo total knee arthroplasty using the Mako Robotic-Arm Assisted System (Stryker, Kalamazoo, Michigan, USA) with the Triathlon Total Knee System. Robotic assistance will be used for preoperative/intraoperative surgical planning, bone preparation, component positioning, and intraoperative assessment of soft-tissue balance. In both groups, all components will be implanted using cemented fixation. Stem extensions may be used selectively on a case-by-case basis.The patella will be managed with conventional patelloplasty in all patients. Closed-suction drains will be used routinely.
Receives: Device: Mako4 Robotic Arm Assisted Total Knee Arthroplasty
conventional total knee arthroplasty using Triathlon Total Knee SystemActive comparatorAll patients will be managed by the same surgical team , performed with the patient in supine position. Prophylactic intravenous antibiotics will be administered 30 minutes before skin incision , using weight-adjusted dosing. An above-knee pneumatic tourniquet will be applied in all cases, and a standard medial parapatellar approach will be used. Patients allocated to the conventional (control) group will undergo total knee arthroplasty using the Triathlon Total Knee System (Stryker, Kalamazoo, Michigan, USA) with standard manual instrumentation and conventional cutting jigs, without robotic assistance. Component sizing, bone preparation, positioning, and soft-tissue balancing will be performed using standard conventional techniques. All components will be implanted using cemented fixation. Stem extensions may be used selectively on a case-by-case basis. The patella will be managed with conventional patelloplasty in all patients. Closed-suction drains will be used routinely.
Receives: Procedure: conventional total knee arthroplasty using Triathlon Total Knee System

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. patient satisfaction (Forgotten Joint Score-12 (FJS-12))

    Patient-reported joint awareness assessed using the 12-item Forgotten Joint Score (FJS-12). The score ranges from 0 to 100, with higher scores indicating less awareness of the operated knee during daily activities and therefore a better outcome.

    Measured: 6 weeks, 3 months, 6 months, and 12 months postoperatively

  2. Patient Satisfaction (2011 Knee Society Score [KSS] Satisfaction Domain)

    Patient satisfaction will be assessed using the satisfaction domain of the 2011 Knee Society Score. Scores range from 0 to 40, with higher scores indicating greater patient satisfaction and therefore a better outcome.

    Measured: 6 weeks, 3 months, 6 months, and 12 months postoperatively

Secondary outcomes (21)
  1. Functional outcome: (2011 Knee Society Score [KSS] Symptoms Domain)

    Symptoms will be assessed using the symptoms domain of the 2011 Knee Society Score (KSS). Scores range from 0 to 25, with higher scores indicating fewer symptoms and a better outcome.

    Measured: 6 weeks, 3 months, 6 months, and 12 months postoperatively

  2. Functional outcome: (2011 Knee Society Score [KSS] Functional Activity Domain)

    Functional activity will be assessed using the functional activity domain of the 2011 Knee Society Score (KSS). Scores range from 0 to 100, with higher scores indicating better functional ability.

    Measured: 6 weeks, 3 months, 6 months, and 12 months postoperatively

  3. Functional outcome: (2011 Knee Society Score [KSS] Expectations Domain)

    Patient expectations will be assessed using the expectations domain of the 2011 Knee Society Score (KSS). Scores range from 0 to 15, with higher scores indicating greater fulfillment of patient expectations.

    Measured: 6 weeks, 3 months, 6 months, and 12 months postoperatively

  4. Functional outcome: (2011 Knee Society Score [KSS] objective knee indicators domain )

    Objective knee status will be assessed using the Objective Knee Score of the 2011 Knee Society Score (KSS), which evaluates symptoms, range of motion, knee stability, and alignment. Scores range from 0 to 100, with higher scores indicating better objective knee status.

    Measured: 6 weeks, 3 months, 6 months, and 12 months postoperatively

  5. Functional Outcome: (Oxford Knee Score [OKS])

    Functional outcome will be assessed using the Oxford Knee Score (OKS), a 12-item patient-reported measure evaluating knee pain and function. Scores range from 0 to 48, with higher scores indicating better knee function and less pain.

    Measured: 6 weeks, 3 months, 6 months, and 12 months postoperatively

  6. Radiological accuracy: Hip-Knee-Ankle angle (HKA)

    Coronal lower-limb alignment will be assessed on standing full-length lower-limb radiographs using the hip-knee-ankle (HKA) angle, measured in degrees. The HKA angle will be determined from the mechanical axes of the femur and tibia. Deviation from the prespecified alignment target will also be recorded. An alignment outlier will be defined according to the prespecified study threshold, including deviation greater than 3 degrees from the intended alignment target where applicable.

    Measured: 6 weeks postoperatively

  7. Radiological accuracy: Knee Society Radiographic Evaluation System (KSRES)

    Postoperative radiographs will be obtained (Xray knees Ap, lateral and if applicable; merchant view) and will be assessed using the Knee Society Radiographic Evaluation System, which provides a standardized assessment of total knee arthroplasty component alignment and fixation. Radiolucent lines and osteolysis will be recorded according to predefined femoral and tibial component zones, and component position will be assessed in the coronal and sagittal planes.

    Measured: immediate postoperative , 6 months and and 12 months postoperatively

  8. Femoral Component Rotational Alignment

    Femoral component rotational alignment will be assessed using postoperative computed tomography (CT). Rotation will be measured in degrees relative to the predefined femoral anatomical reference axis. The magnitude and direction of rotational deviation will be recorded.

    Measured: immediate postoperative

  9. Tibial component rotational alignment

    Tibial component rotational alignment will be assessed using postoperative computed tomography (CT). Rotation will be measured in degrees relative to the predefined tibial anatomical reference axis. The magnitude and direction of rotational deviation will be recorded.

    Measured: immediate postoperative

  10. Patellar Height

    Patellar height will be assessed on standardized lateral knee radiographs using the Caton-Deschamps Index (CDI). The index is calculated as the ratio between the distance from the inferior edge of the patellar articular surface to the anterosuperior angle of the tibial plateau and the length of the patellar articular surface. Higher values indicate a relatively higher patellar position.

    Measured: Immediate postoperative period, 6 months, and 12 months postoperatively

  11. Operative Time (minutes)

    Total operative time will be recorded in minutes from skin incision to completion of skin closure.

    Measured: Intraoperative

  12. perioperative Blood Loss

    Measured perioperative blood loss will be calculated as the sum of estimated intraoperative blood loss (calculated from suction canister volume after subtraction of irrigation fluid plus gravimetric assessment of blood absorbed by surgical swabs and sponges.) and cumulative postoperative closed-suction drain output, expressed in milliliters.

    Measured: From the start of surgery until drain removal, typically within 24-48 hours postoperatively

  13. Requirement for Soft-Tissue Release

    The number and proportion of participants requiring one or more soft-tissue releases during total knee arthroplasty to achieve satisfactory ligament balance will be recorded.

    and also , the specific soft-tissue structure or structures released to achieve ligament balance will be recorded. These may include the medial collateral ligament, posteromedial capsule, posterior capsule, iliotibial band, lateral collateral ligament, popliteus tendon, or other periarticular soft-tissue structures as clinically indicated.

    Measured: Intraoperative

  14. Final Polyethylene Insert Thickness

    The thickness of the final implanted polyethylene tibial insert will be recorded in millimeters.

    Measured: Intraoperative

  15. intraoperative and postoperative Blood transfusion (Packed RBCS units)

    The number and proportion of participants receiving packed red blood cell transfusion during the intraoperative or postoperative period will be recorded.

    Measured: From the start of surgery through hospital discharge

  16. Length of Hospital Stay ( days)

    Duration of postoperative hospitalization will be measured in days from the date of surgery until hospital discharge.

    Measured: From surgery through hospital discharge

  17. Incidence of infection

    ( prosthetic joint infection ) PJI will be diagnosed according to the 2018 evidence-based International Consensus Meeting (ICM) criteria, based on the presence of a major criterion or fulfillment of the validated weighted minor-criteria scoring system.

    Measured: through study completion, an average of 1 year follow up

  18. periprosthetic fractures

    Measured: From the perioperative period through study completion, up to atleast 12 months postoperatively

  19. neurovascular compromise

    Measured: From the perioperative period through study completion, up to atleast 12 months postoperatively

  20. Deep Vein Thrombosis (DVT)

    The number and proportion of participants developing postoperative deep vein thrombosis will be recorded. DVT will be diagnosed based on clinical suspicion confirmed by appropriate vascular imaging, such as duplex ultrasonography, according to institutional practice.

    Measured: From the perioperative period through study completion, up to atleast 12 months postoperatively

  21. Need for Revision or Reoperation for Implant-Related Failure

    The number and proportion of participants experiencing failure of the implanted total knee arthroplasty components will be recorded. Implant failure will include mechanical failure, clinically significant component loosening, breakage, instability, or any implant-related complication requiring revision or reoperation.

    Measured: From the perioperative period through study completion, up to atleast 12 months postoperatively

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Nov 2026
  2. Study start30 Oct 2026 (estimated)
  3. Primary completion30 Apr 2028 (estimated)
  4. Study completion30 Apr 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Two-arm, parallel-group, randomized controlled trial comparing Mako4 robotic-arm assisted total knee arthroplasty with conventional total knee arthroplasty. Participants will be allocated in a 1:1 ratio using simple computer-generated randomization. Allocation will be concealed by an off-site holder of the randomization sequence until enrollment and assignment. Outcome assessors will be blinded to treatment allocation, while participants and the operating surgical team will not be blinded because of the nature of the interventions.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
70 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07914036
Sponsor's protocol ID
FMASU MD 113/2026
Acronym
RoboTKA
Status last verified
Oct 2026
First submitted
26 Oct 2026
Last updated
3 Nov 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
Yes: De-identified individual participant data underlying the published results may be made available upon reasonable request to the principal investigator, subject to approval by the Institutional Review Board of the Faculty of Medicine, Ain Shams University and applicable institutional data-sharing policies. No directly identifiable participant information will be shared

Publications

  • Sutton PM, Murray JS. The National Joint Registry 22 years on: what have we learned about knee replacements? Orthop Trauma. 2025;39:74-80.

  • Marchand RC, Sodhi N, Anis HK, Ehiorobo J, Newman JM, Taylor K, Condrey C, Hepinstall MS, Mont MA. One-Year Patient Outcomes for Robotic-Arm-Assisted versus Manual Total Knee Arthroplasty. J Knee Surg. 2019 Nov;32(11):1063-1068. doi: 10.1055/s-0039-1683977. Epub 2019 Apr 8.

    PubMed 30959549
  • Choi YJ, Ra HJ. Patient Satisfaction after Total Knee Arthroplasty. Knee Surg Relat Res. 2016 Mar;28(1):1-15. doi: 10.5792/ksrr.2016.28.1.1. Epub 2016 Feb 29.

    PubMed 26955608
  • Kahlenberg CA, Nwachukwu BU, McLawhorn AS, Cross MB, Cornell CN, Padgett DE. Patient Satisfaction After Total Knee Replacement: A Systematic Review. HSS J. 2018 Jul;14(2):192-201. doi: 10.1007/s11420-018-9614-8. Epub 2018 Jun 5.

    PubMed 29983663
  • Gustke KA, Golladay GJ, Roche MW, Jerry GJ, Elson LC, Anderson CR. Increased satisfaction after total knee replacement using sensor-guided technology. Bone Joint J. 2014 Oct;96-B(10):1333-8. doi: 10.1302/0301-620X.96B10.34068.

    PubMed 25274917
  • Onggo JR, Onggo JD, De Steiger R, Hau R. Robotic-assisted total knee arthroplasty is comparable to conventional total knee arthroplasty: a meta-analysis and systematic review. Arch Orthop Trauma Surg. 2020 Oct;140(10):1533-1549. doi: 10.1007/s00402-020-03512-5. Epub 2020 Jun 14.

    PubMed 32537660
  • Abdel MP, Oussedik S, Parratte S, Lustig S, Haddad FS. Coronal alignment in total knee replacement: historical review, contemporary analysis, and future direction. Bone Joint J. 2014 Jul;96-B(7):857-62. doi: 10.1302/0301-620X.96B7.33946.

    PubMed 24986936
  • Insall JN, Dorr LD, Scott RD, Scott WN. Rationale of the Knee Society clinical rating system. Clin Orthop Relat Res. 1989 Nov;(248):13-4.

    PubMed 2805470
  • Murray DW, Fitzpatrick R, Rogers K, Pandit H, Beard DJ, Carr AJ, Dawson J. The use of the Oxford hip and knee scores. J Bone Joint Surg Br. 2007 Aug;89(8):1010-4. doi: 10.1302/0301-620X.89B8.19424.

    PubMed 17785736
  • Behrend H, Giesinger K, Giesinger JM, Kuster MS. The "forgotten joint" as the ultimate goal in joint arthroplasty: validation of a new patient-reported outcome measure. J Arthroplasty. 2012 Mar;27(3):430-436.e1. doi: 10.1016/j.arth.2011.06.035. Epub 2011 Oct 13.

    PubMed 22000572
  • Noble PC, Scuderi GR, Brekke AC, Sikorskii A, Benjamin JB, Lonner JH, Chadha P, Daylamani DA, Scott WN, Bourne RB. Development of a new Knee Society scoring system. Clin Orthop Relat Res. 2012 Jan;470(1):20-32. doi: 10.1007/s11999-011-2152-z.

    PubMed 22065240
  • Meneghini RM, Mont MA, Backstein DB, Bourne RB, Dennis DA, Scuderi GR. Development of a Modern Knee Society Radiographic Evaluation System and Methodology for Total Knee Arthroplasty. J Arthroplasty. 2015 Dec;30(12):2311-4. doi: 10.1016/j.arth.2015.05.049. Epub 2015 May 29.

    PubMed 26122112
  • Hoveidaei AH, Esmaeili S, Ghaseminejad-Raeini A, Pirahesh K, Fallahi MS, Sandiford NA, Citak M. Robotic assisted Total Knee Arthroplasty (TKA) is not associated with increased patient satisfaction: a systematic review and meta-analysis. Int Orthop. 2024 Jul;48(7):1771-1784. doi: 10.1007/s00264-024-06206-4. Epub 2024 May 6.

    PubMed 38705892
  • Scott CE, Howie CR, MacDonald D, Biant LC. Predicting dissatisfaction following total knee replacement: a prospective study of 1217 patients. J Bone Joint Surg Br. 2010 Sep;92(9):1253-8. doi: 10.1302/0301-620X.92B9.24394.

    PubMed 20798443
  • Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007 Apr;89(4):780-5. doi: 10.2106/JBJS.F.00222.

    PubMed 17403800

Questions about this trial

What is this clinical trial studying?

A study testing Mako4 Robotic Arm Assisted Total Knee Arthroplasty and conventional total knee arthroplasty using Triathlon Total Knee System in people with Osteoarthritis (Knee) and Robotic Assisted Arthroplasty, run by Ain Shams University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 3 Nov 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Abdelrahman Amir AbouElEla, Msc (1099353380 ext. +20, abdelrahman.amir.medorth@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

patient satisfaction (Forgotten Joint Score-12 (FJS-12)) (time frame: 6 weeks, 3 months, 6 months, and 12 months postoperatively). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07914036, which also lists 15 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Nov 2026; AzTrials last refreshed its copy on 6 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in